库欣病临床诊断研究进展

doi:10.3969/j.issn.1672-6731.2020.03.006

摘要/Abstract

摘要：

库欣病亦称垂体促肾上腺皮质激素腺瘤，是一种临床罕见且严重的神经内分泌疾病。其诊断主要基于临床表现、影像学检查和内分泌功能测定。随着影像学技术的发展、实验室检查的精细化和基因组学技术的成熟，库欣病的诊断水平显著提高。本文拟从临床表现、影像学检查、内分泌功能测定、分子标志物检测和基因检测方面对库欣病的定性诊断和定位诊断进展进行综述。

关键词: 库欣综合征, 垂体肿瘤, 促肾上腺皮质激素, 综述

Abstract:

Cushing's disease, also known as pituitary adrenocorticotrophin-secreting adenoma, is a rare and serious neuroendocrine disease. At present, the diagnosis of disease is mainly based on the patient's clinical manifestations, imaging examinations and endocrine-related examinations. With the development of imaging technology, the refinement of laboratory tests and the maturation of genomics technology, the diagnostic level of the Cushing's disease has improved significantly. This article will review recent research advances on the qualitative and localized diagnosis of Cushing's disease in clinical manifestations, biochemical detection, imaging diagnostics, molecular markers and genomics detection.

Key words: Cushing syndrome, Pituitary neoplasms, Adrenocorticotropic hormone, Review

孙博文, 冯铭, 张家亮, 康军. 库欣病临床诊断研究进展[J]. 中国现代神经疾病杂志, 2020, 20(3): 162-165.

SUN Bo-wen, FENG Ming, ZHANG Jia-liang, KANG Jun. Advances in clinical diagnosis of Cushing's disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(3): 162-165.

https://journal11.magtechjournal.com/cjcnn/CN/Y2020/V20/I3/162

参考文献

[1] Asa SL, Ezzat S. The pathogenesis of pituitary tumors[J]. Ann Rev Pathol, 2009, 4:97-126.
[2] Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome[J]. Am J Med, 2005, 118:1340-1346.
[3] Lonser RR, Nieman L, Oldfield EH. Cushing's disease:pathobiology, diagnosis, and management[J]. J Neurosurg, 2017, 126:404-417.
[4] Lopez JA, Kleinschmidt-Demasters Bk Bk, Sze CI, Woodmansee WW, Lillehei KO. Silent corticotroph adenomas:further clinical and pathological observations[J]. Hum Pathol, 2004, 35:1137-1147.
[5] Castro MD, Moreira AC. Screening and diagnosis of Cushing's syndrome[J]. Arq Bras Endocrinol Metabol, 2007, 51:1191-1198.
[6] Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome:a consensus statement[J]. J Clin Endocrinol Metab, 2003, 88:5593-5602.
[7] Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states[J]. Endocr Rev, 1998, 19:647-672.
[8] Carroll T, Raff H, Findling JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome:a meta-analysis[J]. Endocr Pract, 2009, 15:335-342.
[9] Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients[J]. J Clin Endocrinol Metab, 2009, 94:456-462. Dugué MA, Grabar S, Fulla Y,
[10] Yaneva M, Mosnier-Pudar H, Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes[J]. J Clin Endocrinol Metab, 2004, 89:3345-3351.
[11] Wester VL, van Rossum EF. Clinical applications of cortisol measurements in hair[J]. Eur J Endocrinol, 2015, 173:M1-10.
[12] Leães CG, Pereira-Lima JF, Lenhardt R, Silveira VM, Ferreira NP, Oliveira MC. Spoiled gradient recalled acquisition in the steady state for magnetic resonance imaging diagnosis of Cushing disease[J]. Arq Neuropsiquiatr, 2009, 67:127-129.
[13] Zada G. Diagnosis and multimodality management of Cushing's disease:a practical review[J]. Int J Endocrinol, 2013:ID893781.
[14] Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F; Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Diagnosis and management of Cushing's syndrome:results of an Italian multicentre study[J]. J Clin Endocrinol Metab, 1999, 84:440-448.
[15] Ludecke DK, Flitsch J, Knappe UJ, Saeger W. Cushing's disease:a surgical view[J]. J Neurooncol, 2001, 54:151-166.
[16] Portocarrero-Ortiz L, Bonifacio-Delgadillo D, Sotomayor-González A, Garcia-Marquez A, Lopez-Serna R. A modified protocol using half-dose gadolinium in dynamic 3-Tesla magnetic resonance imaging for detection of ACTH-secreting pituitary tumors[J]. Pituitary, 2010, 13:230-235.
[17] Erickson D, Erickson B, Watson R, Patton A, Atkinson J, Meyer F, Nippoldt T, Carpenter P, Natt N, Vella A, Thapa P. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome[J]. Clin Endocrinol (Oxf), 2010, 72:793-799.
[18] Kim LJ, Lekovic GP, White WL, Karis J. Preliminary experience with 3-Tesla MRI and Cushing's disease[J]. Skull Base, 2007, 17:273-277.
[19] de Rotte AA, van der Kolk AG, Rutgers D, Zelissen PM, Visser F, Luijten PR, Hendrikse J. Feasibility of high-resolution pituitary MRI at 7.0 Tesla[J]. Eur Radiol, 2014, 24:2005-2011.
[20] Oldfield EH. Surgical management of Cushing's disease:a personal perspective[J]. Clin Neurosurg, 2011, 58:13-26.
[21] Patronas N, Bulakbasi N, Stratakis CA, Lafferty A, Oldfield EH, Doppman J, Nieman LK. Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors[J]. J Clin Endocrinol Metab, 2003, 88:1565-1569.
[22] Tanei T, Nagatani T, Nakahara N, Watanabe T, Nishihata T, Nielsen ML, Takebayashi S, Hirano M, Wakabayashi T. Use of high-field intraoperative magnetic resonance imaging during endoscopic transsphenoidal surgery for functioning pituitary microadenomas and small adenomas located in the intrasellar region[J]. Neurol Med Chir (Tokyo), 2013, 53:501-510.
[23] Li YN, Tao W, Ren ZY, Su CB, Wang RZ, Cheng X, Yang Y, Ma WB. Diagnosis of pituitary microadenoma with ¹⁸F-FDG positron emission tomography[J]. Zhongguo Er Bi Yan Hou Tou Jing Wai Ke, 2007, 14:131-133.[李永宁, 陶蔚, 任祖渊, 苏长保, 王任直, 程欣, 杨义, 马文斌. ¹⁸F-脱氧葡萄糖正电子发射断层扫描诊断垂体微腺瘤[J]. 中国耳鼻咽喉头颈外科, 2007, 14:131-133.]
[24] Patt HP, Lele V, Lila A, Bandgar T, Shah N. Utility of hCRH-stimulated (18) FFDG PET-CT scan in localisation of pituitary microadenoma in Cushing's disease[J]. J Med Imaging Radiat Oncol, 2014, 58:213.
[25] Hyun SH, Choi JY, Lee KH, Choe YS, Kim BT. Incidental focal ¹⁸F-FDG uptake in the pituitary gland:clinical significance and differential diagnostic criteria[J]. J Nucl Med, 2011, 52:547-550.
[26] Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers:occult adenomas in the general population[J]. Ann Inter Med, 1994, 120:817-820.
[27] Erickson D, Erickson B, Watson R, Patton A, Atkinson J, Meyer F, Nippoldt T, Carpenter P, Natt N, Vella A, Thapa P. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome[J]. Clin Endocrinol (Oxf), 2010, 72:793-799.
[28] Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome[J]. J Clin Endocrinol Metab, 1993, 77:1308-1312.
[29] Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, Grossman AB. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome[J]. J Clin Endocrinol Metab, 2002, 87:1640-1645.
[30] Suda T, Kageyama K, Nigawara T, Sakihara S. Evaluation of diagnostic tests for ACTH-dependent Cushing's syndrome[J]. Endoc J, 2009, 56:469-476.
[31] Salgado LR, Fragoso MC, Knoepfelmacher M, Machado MC, Domenice S, Pereira MA, de Mendonca BB. Ectopic ACTH syndrome:our experience with 25 cases[J]. Eur J Endocrinol, 2006, 155:725-733.
[32] Paul M, Nils P. Classification and pathophysiology of Cushing's Syndrome[M]//Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams textbook of endocrinology. 12th ed. Philadelphia:Elsevier Saunders, 2011:479-545.
[33] Wind JJ, Lonser RR, Nieman LK, DeVroom HL, Chang R, Oldfield EH. The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing's disease[J]. J Clin Endocrinol Metab, 2013, 98:2285-2293.
[34] Potts MB, Shah JK, Molinaro AM, Blevins LS, Tyrrell JB, Kunwar S, Dowd CF, Hetts SW, Aghi MK. Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing's disease[J]. J Neurooncol, 2014, 116:593-600.
[35] Oldfield EH. Surgical management of Cushing's disease:a personal perspective[J]. Clin Neurosurg, 2011, 58:13-26.
[36] Feng M, Liu Z, Liu X, Zhang X, Bao X, Yao Y, Deng K, Xing B, Lian W, Zhu H, Lu L, Wang R. Tumour lateralization in Cushing's disease by inferior petrosal sinus sampling with desmopressin[J]. Clin Endocrinol (Oxf), 2018, 88:251-257.
[37] Chen S, Chen K, Wang S, Zhu H, Lu L, Zhang X, Tong A, Pan H, Wang R, Lu Z. The optimal cutoff of BIPSS in differential diagnosis of ACTH-dependent Cushing's syndrome:Is stimulation necessary[J]? J Clin Endocrinol Metab, 2019.[Epub ahead of print]
[38] Page-Wilson G, Freda PU, Jacobs TP, Khandji AG, Bruce JN, Foo ST, Meece K, White A, Wardlaw SL. Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome[J]. J Clin Endocrinol Metab, 2014, 99:E1838-1845.
[39] Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, Mao Y, Li YM, Hu RG, Zhang ZY, Ye HY, Shen M, Shou XF, Li ZQ, Peng H, Wang QZ, Zhou DZ, Qin XL, Ji J, Zheng J, Chen H, Wang Y, Geng DY, Tang WJ, Fu CW, Shi ZF, Zhang YC, Ye Z, He WQ, Zhang QL, Tang QS, Xie R, Shen JW, Wen ZJ, Zhou J, Wang T, Huang S, Qiu HJ, Qiao ND, Zhang Y, Pan L, Bao WM, Liu YC, Huang CX, Shi YY, Zhao Y. Recurrent gain-of-function USP8 mutations in Cushing's disease[J]. Cell Res, 2015, 25:306-317.
[40] Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M. Mutations in the deubiquitinase gene USP8 cause Cushing's disease[J]. Nat Genet, 2015, 47:31-38.

选择文件类型/文献管理软件名称

选择包含的内容

2 库欣病临床诊断研究进展

Advances in clinical diagnosis of Cushing's disease

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	佟志勇. 颅内动脉瘤与脑血管重建术[J]. 中国现代神经疾病杂志, 2024, 24(8): 595-598.
[2]	佟志勇. 脑血管重建术历史沿革[J]. 中国现代神经疾病杂志, 2024, 24(8): 599-605.
[3]	金凌骥, 胡俊文, 李寅, 王林. 复杂颅内动脉瘤的颅内-颅内血管搭桥术[J]. 中国现代神经疾病杂志, 2024, 24(8): 606-612.
[4]	刘佩玺, 史源, 朱巍. 血流导向时代颅内全域脑血管搭桥术治疗颅内动脉瘤之应用方略[J]. 中国现代神经疾病杂志, 2024, 24(8): 613-618.
[5]	张峰, 孟凡刚. 帕金森病自主神经功能障碍丘脑底核脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 510-515.
[6]	吴桂智, 田宏. Meige综合征脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 516-521.
[7]	孟凡刚, 张建国. 耳后磨骨槽技术在脑深部电刺激术中的应用[J]. 中国现代神经疾病杂志, 2024, 24(7): 522-524.
[8]	陈琳, 潘华. 功能性震颤的电生理诊断[J]. 中国现代神经疾病杂志, 2024, 24(7): 573-578.
[9]	魏俊吉, 常健博. 深入基层医院普及神经外科重症管理理念[J]. 中国现代神经疾病杂志, 2024, 24(6): 403-406.
[10]	史若琳, 高秀洁, 崔家宁, 邵妍, 谢璐霜, 刘毅. 5-羟色胺与帕金森病非运动症状研究进展[J]. 中国现代神经疾病杂志, 2024, 24(6): 497-501.
[11]	李海峰. 在进入靶向治疗的时代激素仍然是重症肌无力治疗的基础[J]. 中国现代神经疾病杂志, 2024, 24(5): 295-307.
[12]	许鸿嘉, 舒崖清, 王蘋, 李蕃, 许顺良, 邱伟, 马晓宇. 抗水通道蛋白4抗体阳性视神经脊髓炎谱系疾病诊断与治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 308-314.
[13]	黄瑀, 廖金池, 舒崖清. 抗N-甲基-D-天冬氨酸受体脑炎睡眠障碍研究进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 315-319.
[14]	刘彩云, 金涛. 树突状细胞在多发性硬化免疫治疗中的应用[J]. 中国现代神经疾病杂志, 2024, 24(5): 320-330.
[15]	王军成, 赵岳阳, 杨强, 蒯涛, 潘亚文. HMGB1基因调控胶质瘤恶性生物学行为研究进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 391-397.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 库欣病临床诊断研究进展

Advances in clinical diagnosis of Cushing's disease

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价